Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 03, 2020
BioAscent enhanced its service offering with a £1m/$1.3m investment in new instrumentation and equipment.
read more
Monday, September 21, 2020
Alimera Sciences Europe has signed a distribution agreement with Medis for the exclusive sales and distribution of ILUVIEN in the Czech Republic and Austria.
read more
Tuesday, December 02, 2014
SGS Life Science Services, the leading pharmaceutical clinical and bioanalytical contract solutions provider, today announced that it is to invest in its Mumbai, India, facility, in a move which will see the current 1393 sq m laboratory more than ...
read more
Wednesday, April 05, 2017
Sharp Clinical Services, part of UDG Healthcare plc, has announced a £9 million investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales.
read more
Wednesday, October 22, 2025
Serán BioScience has announced an expansion of its commercial manufacturing footprint with the development of a new 100,000-square-foot campus in Bend, Oregon.
read more
Wednesday, December 03, 2025
Emerald Clinical Trials announced the appointment of Luke Gill, MSc, MBA, as Vice President, Global Head of Oncology, Medical & Scientific Affairs. This appointment underscores Emerald's continued investment in advancing oncology innovation and ...
read more
Evidation Health announced it has closed a $10 million funding round led by Sanofi-Genzyme BioVentures, the corporate venture capital arm of Sanofi.
read more
Thursday, January 04, 2018
INC Research/inVentiv Health has changed its brand identity to Syneos Health effective January 4, 2018.
read more
OWP Pharmaceuticals has chosen EVERSANA to provide commercialization support for the U.S. launch of SUBVENITE® (lamotrigine) oral suspension, a recently FDA-approved treatment for epilepsy and bipolar disorders.
read more
Tuesday, January 07, 2014
The German pharmaceutical, chemical and
life science company Merck KGaA, Darmstadt, Germany, broke ground today on a new
production facility for its Allergopharma unit in Reinbek near Hamburg. The new facility,
which is estimated to cost nearly € ...
read more
Friday, December 22, 2017
PixarBio developers of NeuroRelease NR14 announce an agreement between PSI, a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14.
read more
Heat Biologics, Inc. announced a planned development partnership of its Scorpion Biological Services subsidiary with a private developer, the State of Kansas and local and university affiliates, to support the development of a new biodefense-focused ...
read more
Wednesday, September 03, 2025
Andelyn Biosciences has partnered with Tern Therapeutics to perform late-stage Process Performance Qualification (PPQ) manufacturing of Tern's TTX-381 program. TTX-381 is an investigational gene therapy targeting vision loss in children with CLN2 ...
read more
Wednesday, February 27, 2019
PAREXEL announced several new appointments that will enhance the company’s oncology expertise as oncology trials grow in number and complexity.
read more
Monday, February 24, 2020
Dipharma Francis announced the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo MI.
read more